Hello, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? Perhaps a cup or two of stimulation is in order. As you know, a prescription is not required. Moreover, our sources tell us that this is “national cup of stimulation day.” How about that? So feel free to indulge as you attack the laundry list of meetings and deadlines that await. Meanwhile, we have once again assembled a list of tidbits for you to peruse and help you on your way. Hope you have a smashing day and, as always, do drop us a line when you hear something interesting. …
Regulatory clearance of the Pfizer (PFE) and BioNTech (BNTX) Covid-19 vaccine for young children may not come until November, after the companies said they will not ask for the green light for a few weeks, according to The Wall Street Journal. The companies said they provided U.S. health regulators with data from a recent study of their vaccine in children 5 to 11 years old and would file an application asking the U.S. Food and Drug Administration to authorize use in the coming weeks, though they had previously targeted submitting the application as early as the end of September.
For more than a year, misinformation that ivermectin is effective at treating or preventing Covid-19 has run rampant. But demand has strained the equine and livestock world, The New York Times says. Certain versions of the drug can treat head lice and other ailments in people; other formulations — which come in forms such as liquid and paste — are common across the equine and livestock industries as ways to get rid of worms and parasites. Now, one national retailer of animal supplies recently raised the price of ivermectin paste to $6.99 a tube from $2.99. And a Las Vegas farm supply store started selling the medicine only to customers who could prove they had a horse.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
